Intent to Sole Source Life Technologies Corpo. for Thermo QS 7 Pro Dx rRt PCR Instrument

The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to procure Thermo QuantStudio 7 Pro Dx, an FDA-approved (IVD cleared) rRT PCR that can be used in conjunction with the CDC FDA-approved and FDA-authorized in vitro diagnostics for detection of Influenza nad SARS-CoV-2 viruses from clinical samples. It uses as 96-well block or a 384-well block fro data collection, and can multiplex up to 5 targets, allowing CDC to adapt FDA-approved and authorized IVD and EUA diagnostics for influenza and SARS-CoV-2 to run on this instrument. Thermo Fisher will manufatcure supplies and provide services to the Thermo QuantStudio 7 Pro Dx Instrument.
We propose to contract with Life Technologies Corporation, a subsidiary of ThermoFisher Scientific, located at 5781 Van Allen Way Carlsbad, CA 92008, is identified as a vendor capable of providing the QuantStudio 7 Pro Dx needed.

This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 10 U.S.C. 2304(c)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals.

This notice of intent is not a request for competitive quotations; however, all quotations/responses received within six (6) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to contract specialist at urv3@cdc.gov by 3:00pm, 6th September.